Commentary on Pinkerton (2010): Drug consumption rooms - Time to accept their worth

Addiction

Volumn 105, Issue 8, 2010, Pages 1437-1438

  Lloyd, Charlie ^a   Godfrey, Christine ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Drug consumption rooms; economic evaluation; HIV infection

Indexed keywords

CANADA; ECONOMICS; HARM REDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PREVENTIVE HEALTH SERVICE; SANITATION;

BRITISH COLUMBIA; HARM REDUCTION; HIV INFECTIONS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; PUBLIC FACILITIES;

EID: 77954477532     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03027.x     Document Type: Note

References (8)

1. Hunt N. An Overview of Models of Delivery of Drug Consumption Rooms, Paper C, Independent Working Group on Drug Consumption Rooms.
2. Hedrich D. European Report on Drug Consumption Rooms.
3. Lloyd C., Hunt N. Drug consumption rooms: an overdue extension to harm reduction policy in the UK? Int J Drug Policy 2007 18 : 5 9.
4. Medically Supervised Injecting Centre Evaluation Committee. Final Report of the Evaluation of the Sydney Medically Supervised Injecting Centre.
5. Bayoumi A. M., Zaric G. S. The cost-effectiveness of Vancouver's supervised injecting facility. Can Med Assoc J 2008 179 : 1143 1151.
6. Pinkerton S. D. Is Vancouver Canada's supervised injection facility cost-saving? Addiction 2010 105 : 1429 1436.
7. Andreson M. A., Boyd N. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. Int J Drug Policy 2010 21 : 70 6.
8. Health Canada. I-Track. Enhanced Surveillance of Risk Behaviours among Injecting Drug Users in Canada. 2006. Phase 1 Report. Ottawa: Public Health Agency of Canada.